SXTP
60 DEGREES PHARMACEUTICALS, INC.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 2× in & out | Q4 2024 | Q1 2025 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at 60 DEGREES PHARMACEUTICALS, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Dec 16, 2025 — the most recent Form 4 on file — not from today.
- Form 40001213900-25-122379Dec 16, 2025
- Form 40001213900-25-120948Dec 12, 2025
- Form 40001213900-25-087681Sep 15, 2025
- Form 40001213900-25-076984Aug 14, 2025
- Form 40001213900-25-076983Aug 14, 2025
- Form 40001213900-25-052709Jun 9, 2025
- Form 40001213900-25-051700Jun 5, 2025
- Form 40001213900-25-006572Jan 24, 2025
- Form 40001213900-25-006569Jan 24, 2025
- Form 40001213900-25-005055Jan 21, 2025
- Form 40001213900-25-005051Jan 21, 2025
- Form 40001213900-24-110269Dec 18, 2024
- Form 40001213900-24-107011Dec 9, 2024
- Form 40001213900-24-101110Nov 21, 2024
- Form 40001213900-24-077746Sep 11, 2024
Fundamentals
XBRL · 60 DEGREES PHARMACEUTICALS, INC.Annual figures sourced directly from 60 DEGREES PHARMACEUTICALS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for 60 DEGREES PHARMACEUTICALS, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KCURRENT REPORTJun 3, 2026
- 8-KCURRENT REPORTMay 18, 2026
- 10-QQuarterly reportMay 15, 2026
- 10-KAnnual reportMar 30, 2026
- 8-KCURRENT REPORTMar 20, 2026
- 8-KCURRENT REPORTMar 13, 2026
- 8-KCURRENT REPORTMar 12, 2026
- 8-KCURRENT REPORTFeb 12, 2026
- 8-KCURRENT REPORTJan 23, 2026
- 8-KCURRENT REPORTJan 21, 2026
- 8-KCURRENT REPORTJan 8, 2026
- 10-QQuarterly reportNov 13, 2025
- 8-KCURRENT REPORTOct 10, 2025
- 8-KCURRENT REPORTSep 9, 2025
- 8-KCURRENT REPORTSep 5, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q4 2024 | Q1 2025 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | open | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.